¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"passive agglutination"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • passive edema
    ¼öµ¿ºÎÁ¾
  • passive euthanasia
    ¼Ò±ØÀû¾È¶ô»ç
  • passive exercise
    Çǵ¿¿îµ¿
  • passive hemagglutination
    ¼öµ¿ÀûÇ÷±¸ÀÀÁý
  • passive hyperemia
    ¼öµ¿ÃæÇ÷
  • passive immunity
    ¼öµ¿¸é¿ª
  • passive immunization
    ¼öµ¿¸é¿ªÈ­
  • passive movement
    ¼öµ¿¿îµ¿, Çǵ¿¿îµ¿
  • passive observer
    ¼öµ¿°üÂûÀÚ
  • passive sensitization
    ¼öµ¿¹Î°¨È­
  • passive shimming
    ¼öµ¿º¸Á¤
  • passive smoking
    °£Á¢Èí¿¬
  • passive transfer
    ¼öµ¿Àü´Þ
  • passive transport
    ¼öµ¿¿î¹Ý
  • reverse passive anaphylaxis
    ¿ª¼öµ¿¾Æ³ªÇʶô½Ã½º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • passive diffusion
    ¼öµ¿È®»ê
  • passive edema
    ¼öµ¿ºÎÁ¾
  • passive euthanasia
    ¼öµ¿¾È¶ô»ç
  • passive exercise
    Çǵ¿¿îµ¿
  • passive hemagglutination
    ¼öµ¿ÀûÇ÷±¸ÀÀÁý
  • passive hyperemia
    ¼öµ¿ÃæÇ÷
  • reversed passive hemagglutination
    ¿ª¼öµ¿ÀûÇ÷±¸ÀÀÁý
  • passive immunity
    ¼öµ¿¸é¿ª
  • passive immunization
    ¼öµ¿¸é¿ªÈ­
  • passive movement
    Çǵ¿¿îµ¿
  • passive observer
    ¼öµ¿°üÂûÀÚ
  • passive
    ¼öµ¿-, Çǵ¿-
  • passive sensitization
    ¼öµ¿¹Î°¨
  • passive shimming
    ¼öµ¿º¸Á¤
  • passive smoking
    °£Á¢Èí¿¬
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • agglutination test
    ÀÀÁý½ÃÇè.
  • agglutination test
    ÀÀÁý½ÃÇè
  • agglutination titer
    ÀÀÁý¿ª°¡(¡­æ³Ê¤).
  • agglutination, indirect
    °£Á¢ÀÀÁý¹ý
  • agglutination, reverse
    ¿ªÀÀÁý¹ý
  • agglutination, slide
    ½½¶óÀ̵åÀÀÁý¹ý
  • agglutination, tube
    ½ÃÇè°üÀÀÁý¹ý
  • agglutination<³ª> agglutinatio
    ÀÀÁý(¹ÝÀÀ), ±³Âø(Îïó·).
  • indirect agglutination
    °£Á¢ÀÀÁý(¹ÝÀÀ).
  • inhibition test, agglutination
    ÀÀÁý¾ïÁ¦½ÃÇè, ÀÀÁýÀúÁö½ÃÇè
  • platelet agglutination
    Ç÷¼ÒÆÇÀÀÁý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • direct agglutination test
    Á÷Á¢ÀÀÁý½ÃÇè
  • indirect agglutination
    °£Á¢ÀÀÁý(¹ÝÀÀ).
  • inhibition test, agglutination
    ÀÀÁý¾ïÁ¦½ÃÇè, ÀÀÁýÀúÁö½ÃÇè
  • intravascular agglutination
    Ç÷°ü³»ÀÀÁý(Ì´Ë´?Ëô̤).
  • latex agglutination
    ¶óÅØ½ºÀÀÁý
  • latex agglutination inhibition reaction =LAIR
    ¶óÅØ½ºÀÀÁýÀúÁö¹ÝÀÀ.
  • latex agglutination test
    ¶óÅØ½ºÀÀÁý½ÃÇè
  • latex agglutination test
    ¶óÅØ½ºÀÀÁý½ÃÇè.
  • latex agglutination test
    ¶óÅØ½º ÀÀÁý½ÃÇè
  • leptospira agglutination-lysis test
    ·¾Å佺ÇǶó±Õ ÀÀÁý-¿ëÇØ°Ë»ç
  • leukocyte agglutination
    ¹éÇ÷±¸ÀÀÁý
  • macroscopic agglutination
    À°¾ÈÀû ÀÀÁý¹ÝÀÀ(¡­ëêó¢Úãëë).
  • major agglutination
    ÁÖÀÀÁý¼Ò.
  • microscopic agglutination
    Çö¹Ì°æÀû ÀÀÁý (¡­ëêó¢).
  • microscopic agglutination
    Çö¹Ì°æÀû ÀÀÁý (¡­ëêó¢).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
FPM filter paper microscopic [test]; full passive movements
PA panic attack; pantothenic acid; paralysis agitans; paranoia; passive aggressive; pathology; patient'...
PAP pancreatitis-associated protein; Papanicolaou [test]; papaverine; passive-aggressive personality; pa...
PAR participating provider; passive avoidance reaction; perennial allergic rhinitis; photosynthetically ...
pass passive
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PCA Passive Cutaneous Anaphylaxis
PHA Passive Haemagglutination
PHN Passive Heymann nephritis
PCA Passive cutaneous anaphylactic
PHA Passive hemagglutination assays
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • passive hyperemia
    ¼öµ¿¼º ÃæÇ÷
  • passive movement
    ¼öµ¿ ¿îµ¿, Çǵ¿ ¿îµ¿
  • passive muscle stretching
    ¼öµ¿Àû ±Ù ½ÅÀå
  • passive range of motion
    ¼öµ¿Àû ¿îµ¿ ¹üÀ§
    ´Ù¸¥ »ç¶÷À̳ª ±â°è ¶Ç´Â ¿ÜºÎÀÇ Èû¿¡ ÀÇÇÏ¿© ±³ÇÕ, °ü·Ã °üÀý³¶, Àδë, ±ÙÀ°À¸·Î Àü´ÞµÈ ¿îµ¿.
  • passive resistive stretch
    ¼öµ¿Àû ÀúÇ× ½ÅÀü
    ¹Ý´ëµÇ´Â Èû¿¡ ´ëÇÏ¿© ±ÙÀ°À» Ȱ¼ºÈ­½ÃŲ ´ÙÀ½ ½ÅÀü½ÃÅ´À¸·Î¼­ ±ÙÀ°ÀÇ ±æÀ̸¦ Áõ°¡Çϵµ·Ï °í¾ÈµÈ ¿îµ¿.
  • passive stretch
    ¼öµ¿Àû ½ÅÀå, ¼öµ¿Àû ½ÅÀü
  • passive stretching
    ¼öµ¿Àû ½ÅÀå
  • passive transport
    Çǵ¿Àû ¿î¹Ý, Çǵ¿Àû À̵¿, ¼öµ¿Àû À̵¿
  • passive-aggressive personality
    ¼öµ¿Àû °ø°Ý¼º ÀΰÝ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
indirect agglutination Agglutination of particles that have been coated with soluble antigen, by antiserum specific for the adsorbed antigen.
Synonym: indirect agglutination.
(05 Mar 2000)
false agglutination 1. Agglomeration of particles in solution which does not involve antigen-antibody combination.
Synonym: false agglutination.
Synonym: rouleaux formation.
(05 Mar 2000)
latex agglutination Also known as latex particle agglutination, for detection of antibodies is identical to haemagglutination in principle, but the substitution of smaller, antigen-coated latex particles for erythrocytes results in improved sensitivity and reagent longevity. Alternatively, antibodies can be absorbed to the latex particles (under appropriate ionic and pH conditions) by binding to the Fc region of antibodies, leaving the Fab region free to interact with antigens present in the applied specimens. This phenomenon has made latex agglutination a popular technique for detecting antigens as well.
(05 Mar 2000)
latex agglutination test A passive agglutination test in which antigen is adsorbed onto latex particles which then clump in the presence of antibody specific for the adsorbed antigen.
Synonym: latex fixation test.
(05 Mar 2000)
artificial passive immunity See: acquired immunity.
(05 Mar 2000)
passive Neither spontaneous nor active, not produced by active efforts.
Origin: L. Passivus
(18 Nov 1997)
passive-aggressive behaviour Apparently compliant behaviour, with intrinsic obstructive or stubborn qualities, to cover deeply felt aggressive feelings that cannot be more directly expressed.
(05 Mar 2000)
passive-aggressive personality A personality disorder in which aggressive feelings are manifested in passive ways, especially through mild obstructionism and stubbornness.
(05 Mar 2000)
passive-aggressive personality disorder A personality disorder characterised by an indirect resistance to demands for adequate social and occupational performance; anger and opposition to authority and the expectations of others that is expressed covertly by obstructionism, procrastination, stubbornness, dawdling, forgetfulness, and intentional inefficiency.
(12 Dec 1998)
passive anaphylaxis A reaction resulting from inoculation of antigen in an animal previously inoculated intravenously with specific antiserum from another animal, a latent period being required between the two inoculations.
Synonym: antiserum anaphylaxis.
(05 Mar 2000)
passive atelectasis The pulmonary collapse that occurs due to a space-occupying intrathoracic process such as pneumothorax or hydrothorax.
(05 Mar 2000)
passive clot A clot formed in an aneurysmal sac consequent to the cessation or slowing of circulation through the aneurysm.
(05 Mar 2000)
passive congestion Congestion caused by obstruction or slowing of the venous drainage, resulting in partial stagnation of blood in the capillaries and venules.
(05 Mar 2000)
passive cutaneous anaphylaxis An evanescent cutaneous reaction occurring when antibody is injected into a local area on the skin and antigen is subsequently injected intravenously along with a dye. The dye makes the rapidly occurring capillary dilatation and increased vascular permeability readily visible by leakage into the reaction site. Pca is a sensitive reaction for detecting very small quantities of antibodies and is also a method for studying the mechanisms of immediate hypersensitivity.
(12 Dec 1998)
passive cutaneous anaphylaxis test An animal is injected intradermally with antibody (usually IgE) and subsequently challenged intravenously with a mixture of antigen and Evans blue dye 24-48 hours later. A dark blue area indicates a positive reaction due to the leakage of the dye at the site of antigen-antibody reactions.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á